2008
DOI: 10.1016/s1701-2163(16)32867-5
|View full text |Cite
|
Sign up to set email alerts
|

Ethical Issues Associated With the Introduction of New Surgical Devices, or Just Because We Can, Doesn’t Mean We Should

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
3
3

Relationship

1
5

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 12 publications
0
28
0
Order By: Relevance
“…The evidence provided in the licensing process is not published, and therefore this process is not identified in the medical literature. TVT Secur, like many devices in this area of practice, was licensed in Europe, the US and Canada on the basis of a predicate licensed moderate risk device, so that no additional evidence of safety or efficacy was required [1][2][3][4]. Ethicon claimed the device was substantially equivalent to the company's TVT and TVT-O devices already on the market, and released the TVT Secur accompanied by data on the outcome and follow-up of the older devices.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…The evidence provided in the licensing process is not published, and therefore this process is not identified in the medical literature. TVT Secur, like many devices in this area of practice, was licensed in Europe, the US and Canada on the basis of a predicate licensed moderate risk device, so that no additional evidence of safety or efficacy was required [1][2][3][4]. Ethicon claimed the device was substantially equivalent to the company's TVT and TVT-O devices already on the market, and released the TVT Secur accompanied by data on the outcome and follow-up of the older devices.…”
Section: Resultsmentioning
confidence: 99%
“…the challenges created by such derivative moderate risk devices for evidence-driven policy and clinical practice. In particular, rigorous objective evaluation of innovations (preferably through clinical trials) prior to their introduction, as recommended by McKinlay and advocated by critics of the commercialization of medical devices [2][3][4]9,10], seems increasingly unlikely.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…5 During the training program in WLH a qualified laparoscopic surgeons will guide the trainees how to assess the effectiveness and safety of a new laparoscopic surgical device before using it. Because human dignity is the priority in WLH, Professor Mishra obliges himself to teach the trainees how to obtain informed consent from patients in a manner that is comprehensible and in accordance with the language, customs and culture of the patient.…”
Section: Introductionmentioning
confidence: 99%